Flagship explainer
How BioXcel Therapeutics, Inc. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $642000 | 100% |
| |
| Cost of revenue | $164000 | 26% |
|
| $478000 | 74% |
| |
| −$50.5M | −7860% |
| |
| Income before tax | −$69.9M | −10887% |
|
| Income tax | $0 | 0% |
|
| −$69.9M | −10887% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001104659-26-036214